Testing tumor genetics in young people with bone sarcomas
Part of Cancer clinical trials.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must be osteosarcoma, Ewing sarcoma, or synovial sarcoma confirmed by pathology (microscope testing).
- You can be either newly diagnosed or have cancer that has come back (relapsed) or not responded (refractory).
- You must be 24 years old or younger.
- You (or your parent/legal guardian) must sign consent for genetic testing on the tumor sample.
- You must have a fresh tumor sample available and a small blood sample (10 ml) for testing.
- A pathologist must be able to review your tumor sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study (it mainly watches and records care) for people with high-grade osteosarcoma in an arm or leg. It may help doctors learn which care approaches work best for younger patients with localized disease.
This study aims to create new laboratory models to better understand sarcomas and cancers that have spread to the bone or lungs. By using donated tumor tissue and blood, researchers hope to learn how these cancers grow and develop, which could lead to better treatments in the future.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This research study follows young people newly diagnosed with osteosarcoma (a type of bone cancer) who are receiving standard chemotherapy. Researchers will collect information about how the cancer responds to treatment and study biological samples to better understand the disease.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
Hear when a new Diagnosed or Relapsed/Refractory Sarcomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.